Report
Our reports provide latest industry trends, forecasts, company profiles, competitive landscape, and strategic insights.
Europe Blood Transfusion Diagnostics Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product (Instruments & Kits and Reagents), Application (Blood Grouping and Disease Screening), and End User (Hospitals, Diagnostic Laboratories, Blood Banks, and Plasma Fractionation Companies)
- Report Code : BMIRE00027398
- Pages : 140
The Europe blood transfusion diagnostics market is expected to grow from US$ 1,272.35 million in 2022 to US$ 1,858.70 million by 2028. It is estimated to grow at a CAGR of 6.5% from 2022 to 2028.
Rapid Increase in Prevalence of Chronic Diseases Boosts Market Growth
Populations across the world are undergoing many lifestyle changes, leading to a steady increase in the prevalence of chronic medical conditions. Continuous urbanization has been driving people toward sedentary lifestyles. The modernization of various residential, commercial, and industrial facilities has led to a reduction in physical activities among people while they are continuously under stress caused by personal, professional, and societal factors. Blood transfusion is a part of the treatment of chronic diseases such as anemia, cancer (some types), thalassemia, hemophilia, and sickle cell disease. The growing burden of chronic diseases affects public health, societies, and economies. Blood transfusion diagnostics are widely used in various surgical procedures, including cardiac surgeries and other invasive procedures. Chronic diseases, such as cancer, cardiovascular diseases, and renal disorders, are generally treated via surgical procedures, which are associated with a chance of excessive blood loss. Hence, fresh blood is infused into patients to maintain their blood levels. Blood transfusion diagnostics solutions are used during the blood infusion or reinfusion processes. Hence, the blood transfusion diagnostics market in Europe is growing with a rapid increase in the prevalence of chronic diseases.
Market Overview
Germany and the UK the key contributors to the blood transfusion diagnostics market in Europe. The market progress in these countries can be ascribed to the rising number of surgeries and transplantation procedures. In Germany, blood transfusion procedures are highly regulated. Blood services are offered by four types of organizations—state blood transfusion services, communal blood transfusion services, commercial blood centers, and plasmapheresis centers (of the plasma fractionation industry). The German Red Cross Blood Transfusion Services, Transfusion Services, and the German Society for Transfusion Medicine and Immunohematology [i.e., Deutsche Gesellschaft für Transfusionsmedizin und Immunhämatologie (DGTI)] are actively involved in providing blood transfusion services in the country. According to OECD Health Statistics, the occurrence of hip replacement surgeries in Germany was at ~315 per 100,000 people in 2019. Moreover, ~227 people per 100,000 were operated for knee replacement in 2019. Per the research article titled “Characteristics of Recipients of Red Blood Cell Concentrates in a German Federal State”, 2020, transfusion rates in Germany are significantly higher with ~50–55 RBCs/1,000 population. In Germany, in 2020, 3,518 organs were transplanted, 502 of which were living-donor transplants. The vast majority of instances (54.3%) include kidney transplants, followed by liver transplants (23.5%), lung (9.8%), heart (9.6%), pancreas (2.6%), and small intestine (0.2%) transplants. Thus, an increasing number of organ transplant procedures propel the number of blood transfusion diagnostics procedures in Germany.
Europe Blood Transfusion Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
Europe Blood Transfusion Diagnostics Market Segmentation
The Europe blood transfusion diagnostics market is segmented based on product, application, end user, and country.
Based on product, the Europe blood transfusion diagnostics market is bifurcated into instruments & kits and reagents. The instruments & kits segment held the larger market share in 2022. Based on application, the Europe blood transfusion diagnostics market is bifurcated into blood grouping and disease screening. The disease screening segment held the larger market share in 2022. Based on end user, the Europe blood transfusion diagnostics market is segmented into hospitals, diagnostic laboratories, blood banks, and plasma fractionation companies. The blood banks segment dominated the market in 2022. Based on country, the Europe blood transfusion diagnostics market has been categorized into the UK, Germany, France, Italy, Spain, and Rest of Europe. Our regional analysis states that Germany dominated the market in 2022. Abbott; BAG Diagnostics GmbH; Bio-Rad Laboratories, Inc.; DiaSorin S.p.A.; F. Hoffmann-La Roche Ltd; Grifols, S.A.; Immucor, Inc.; Ortho Clinical Diagnostics (QuidelOrtho Corporation); Quotient Limited; and Thermo Fisher Scientific Inc. are the leading companies operating in the Europe blood transfusion diagnostics market.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Blood Transfusion Diagnostics Market – By Product
1.3.2 Europe Blood Transfusion Diagnostics Market – By Application
1.3.3 Europe Blood Transfusion Diagnostics Market – By End User
1.3.4 Europe Blood Transfusion Diagnostics Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Blood Transfusion Diagnostics Market – Market Landscape
4.1 Overview
4.2 Europe PEST Analysis
4.3 Experts Opinion
5. Europe Blood Transfusion Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rapid Increase in Chronic Diseases
5.1.2 Need for Blood Transfusion due to Rise in Organ Transplants Surgeries
5.2 Market Restraints
5.2.1 Problems associated with Blood Transfusion Services
5.3 Market Opportunities
5.3.1 Elevated Healthcare Expenditure in Emerging Economies
5.4 Future Trends
5.4.1 Technological Developments in Blood Transfusion Diagnostics
5.5 Impact Analysis
6. Blood Transfusion Diagnostics Market– Europe Analysis
6.1 Europe Blood Transfusion Diagnostics Market Revenue Forecast and Analysis
7. Europe Blood Transfusion Diagnostics Market Analysis – By Product
7.1 Overview
7.2 Europe Blood Transfusion Diagnostics Market Revenue Share, by Product (2021 and 2028)
7.3 Instruments and Kits
7.3.1 Overview
7.3.2 Instruments and Kits: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
7.4 Reagents
7.4.1 Overview
7.4.2 Reagents: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
8. Europe Blood Transfusion Diagnostics Market Analysis – By Application
8.1 Overview
8.2 Europe Blood Transfusion Diagnostics Market Revenue Share, by Application (2021 and 2028)
8.3 Disease Screening
8.3.1 Overview
8.3.2 Disease Screening: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
8.4 Blood Grouping
8.4.1 Overview
8.4.2 Blood Grouping: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9. Europe Blood Transfusion Diagnostics Market Analysis – By End User
9.1 Overview
9.2 Europe Blood Transfusion Diagnostics Market Share, by End User, 2021 and 2028, (%)
9.3 Blood Banks
9.3.1 Overview
9.3.2 Blood Banks: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
9.4 Hospitals
9.4.1 Overview
9.4.2 Hospitals: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
9.5 Diagnostic Laboratories
9.5.1 Overview
9.5.2 Diagnostic Laboratories: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
9.6 Plasma Fractionation Companies
9.6.1 Overview
9.6.2 Plasma Fractionation Companies: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
10. Europe Blood Transfusion Diagnostics Market Analysis – Country Analysis
10.1 Overview
10.1.1 Europe: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
10.1.1.1 Germany: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.1 Germany: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.2 Germany: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)
10.1.1.1.3 Germany: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)
10.1.1.1.4 Germany: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)
10.1.1.2 UK: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.1 UK: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.2 UK: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)
10.1.1.2.3 UK: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)
10.1.1.2.4 UK: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)
10.1.1.3 France: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.1 France: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.2 France: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)
10.1.1.3.3 France: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)
10.1.1.3.4 France: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)
10.1.1.4 Italy: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.4.1 Italy: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.4.2 Italy: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)
10.1.1.4.3 Italy: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)
10.1.1.4.4 Italy: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)
10.1.1.5 Spain: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.5.1 Spain: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.5.2 Spain: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)
10.1.1.5.3 Spain: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)
10.1.1.5.4 Spain: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)
10.1.1.6 Rest of Europe: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.6.1 Rest of Europe: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.6.2 Rest of Europe: Blood Transfusion Diagnostics Market, by Product, 2019–2028 (USD Million)
10.1.1.6.3 Rest of Europe: Blood Transfusion Diagnostics Market, by Application, 2019–2028 (USD Million)
10.1.1.6.4 Rest of Europe: Blood Transfusion Diagnostics Market, by End User, 2019–2028 (USD Million)
11. Industry Landscape
11.1 Overview
11.2 Inorganic Growth Strategies
11.2.1 Overview
11.3 Organic Growth Strategies
11.3.1 Overview
12. Company Profiles
12.1 Grifols, S.A.
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Immucor, Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Bio-Rad Laboratories, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Abbott
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Thermo Fisher Scientific Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Ortho Clinical Diagnostics (QuidelOrtho Corporation)
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 DiaSorin S.p.A.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Quotient Limited
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 BAG Diagnostics GmbH
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Financial Overview
12.10.4 SWOT Analysis
12.10.5 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Europe Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (US$ Mn)
Table 2. Germany: Blood Transfusion Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 3. Germany: Blood Transfusion Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 4. Germany: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. UK: Blood Transfusion Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 6. UK: Blood Transfusion Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 7. UK: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 8. France: Blood Transfusion Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 9. France: Blood Transfusion Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 10. France: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 11. Italy: Blood Transfusion Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 12. Italy: Blood Transfusion Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 13. Italy: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 14. Spain: Blood Transfusion Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 15. Spain: Blood Transfusion Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 16. Spain: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Rest of Europe: Blood Transfusion Diagnostics Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 18. Rest of Europe: Blood Transfusion Diagnostics Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 19. Rest of Europe: Blood Transfusion Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 20. Recent Inorganic Growth Strategies
Table 21. Recent Organic Growth Strategies
Table 22. Glossary of Terms
LIST OF FIGURES
Figure 1. Europe Blood Transfusion Diagnostics Market Segmentation
Figure 2. Europe Blood Transfusion Diagnostics Market – By Country
Figure 3. Europe Blood Transfusion Diagnostics Market Overview
Figure 4. Europe Blood Transfusion Diagnostics Market, By Product
Figure 5. Europe Blood Transfusion Diagnostics Market, By Country
Figure 6. Europe: PEST Analysis
Figure 7. Experts Opinion
Figure 8. Impact Analysis: Europe Blood Transfusion Diagnostics Market
Figure 9. Europe Blood Transfusion Diagnostics Market– Revenue Forecast and Analysis
Figure 10. Europe Blood Transfusion Diagnostics Market Revenue Share, by Product (2021 and 2028)
Figure 11. Europe Instruments and Kits: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 12. Europe Reagents: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 13. Europe Blood Transfusion Diagnostics Market Revenue Share, by Application (2021 and 2028)
Figure 14. Europe Screening: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 15. Europe Blood Grouping: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 16. Europe Blood Transfusion Diagnostics Market Share, by End User, 2021 and 2028 (%)
Figure 17. Europe Blood Banks: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
Figure 18. Europe Hospitals: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 19. Europe Diagnostic Laboratories: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
Figure 20. Europe Plasma Fractionation Companies: Blood Transfusion Diagnostics Market, Revenue and Forecast to 2028 (US$ Million)
Figure 21. Europe: Blood Transfusion Diagnostics Market, by Key Country – Revenue (2021) (USD Million)
Figure 22. Europe: Blood Transfusion Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 23. Germany: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 24. UK: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 25. France: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 26. Italy: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. Spain: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Rest of Europe: Blood Transfusion Diagnostics Market – Revenue and Forecast to 2028 (USD Million)
● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe blood transfusion diagnostics market.
● Highlights key business priorities to assist companies to realign their business strategies
● The key findings and recommendations highlight crucial progressive industry trends in the Europe blood transfusion diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
● Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the blood transfusion diagnostics market, as well as those hindering it
● Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
The List of Companies – Europe Blood Transfusion Diagnostics Market
● Abbott
● BAG Diagnostics GmbH
● Bio-Rad Laboratories, Inc.
● DiaSorin S.p.A.
● F. Hoffmann-La Roche Ltd
● Grifols, S.A.
● Immucor, Inc.
● Ortho Clinical Diagnostics (QuidelOrtho Corporation)
● Quotient Limited
● Thermo Fisher Scientific Inc.
At 6.5% CAGR, the Europe Blood Transfusion Diagnostics Market is speculated to be worth US$ 1,858.70 million by 2028, says The Insight Partners
According to The Insight Partners’ research, the Europe blood transfusion diagnostics market was valued at US$ 1,272.35 million in 2022 and is expected to reach US$ 1,858.70 million by 2028, registering an annual growth rate of 6.5% from 2022 to 2028. The need for blood transfusion due to rise in organ transplants surgeries and rapid increase in chronic diseases are the critical factors attributed to the market expansion.
Organ transplant is a surgical procedure performed in case of organ failure. Usually, organ transplant surgeries are conducted for the heart, liver, kidney, and various other organs due to the rising cases of chronic diseases, such as chronic kidney disease (CKD), polycystic kidney disease, cystic fibrosis, and congenital heart disease, which require transplants. These procedures generally take hours, and there is a lot of blood loss and requires the need for blood transfusion. The public-private partnership, in collaboration with transplant coordinators, has significantly contributed to the improvement of organ transplants that require a constant need for blood transfusion. Both developing and developed countries have seen an increase in organ transplant surgeries. For example, developing countries, are emerging as medical tourism destinations. Countries are progressing in terms of providing better and advanced medical treatments. The rising need for organ transplants is among the key factors driving the demand for blood transfusion diagnostics across the region.
On the contrary, problems associated with blood transfusion services hurdles the growth of Europe blood transfusion diagnostics market.
Based on product, the Europe blood transfusion diagnostics market is bifurcated into instruments & kits and reagents. The instruments & kits segment held 67.2% market share in 2022, amassing US$ 854.73 million. It is projected to garner US$ 1,260.85 million by 2028 to expand at 6.7% CAGR during 2022–2028. Based on application, the Europe blood transfusion diagnostics market is bifurcated into blood grouping and disease screening. The disease screening segment held 60.8% market share in 2022, amassing US$ 773.98 million. It is projected to garner US$ 1,138.01 million by 2028 to expand at 6.6% CAGR during 2022–2028. Based on end user, the Europe blood transfusion diagnostics market is segmented into hospitals, diagnostic laboratories, blood banks, and plasma fractionation companies. The blood banks segment held 39.9% market share in 2022, amassing US$ 507.44 million. It is projected to garner US$ 766.07 million by 2028 to expand at 7.1% CAGR during 2022–2028. Based on country, the Europe blood transfusion diagnostics market has been categorized into the UK, Germany, France, Italy, Spain, and rest of Europe. Our regional analysis states that Germany captured 24.8% market share in 2022. It was assessed at US$ 315.85 million in 2022 and is likely to hit US$ 490.17 million by 2028, exhibiting a CAGR of 7.6% during the forecast period. Key players dominating the Europe blood transfusion diagnostics market are Abbott; BAG Diagnostics GmbH; Bio-Rad Laboratories, Inc.; DiaSorin S.p.A.; F. Hoffmann-La Roche Ltd; Grifols, S.A.; Immucor, Inc.; Ortho Clinical Diagnostics (QuidelOrtho Corporation); Quotient Limited; and Thermo Fisher Scientific Inc. among others.
In March 2021, Roche has acquired GenMark Diagnostics, Inc. at a price of US$ 1.8 billion. The acquisition of GenMark is expected to broaden the diagnostics portfolio of Roche for home medical devices. In March 2022, Immucor, a leader in the immunohematology industry, announced that automated monoclonal Jka and Jkb phenotype testing is now available on the NEO Iris/NEO (v2.0). Immucor’s fully automated Jka and Jkb phenotype assay brings ease of use, high sensitivity, and reduced subjectivity for Kidd antigen testing.
Related Reports
- $3,000.00 – $5,000.00
